CDKN1A and neoplasm: These results are consistent with a previously reported role for p21CIP1 in tumor resistance40,41, and with the observation that in certain tumors, accumulation p21CIP1 in the cytoplasm is associated with tumor survival and reduced tumor sensitivity to treatment49–54.